Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus.
作者信息
Sampaziotis Fotios, Griffiths William J H
出版信息
Br J Clin Pharmacol. 2012 May;73(5):826-7. doi: 10.1111/j.1365-2125.2011.04158.x.
Abstract
摘要
相似文献
1
Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus.
Br J Clin Pharmacol. 2012 May;73(5):826-7. doi: 10.1111/j.1365-2125.2011.04158.x.
2
Severe Rifampicin-induced Vitamin K Deficiency Coagulopathy in a Child.
Pediatr Infect Dis J. 2020 Sep;39(9):833-834. doi: 10.1097/INF.0000000000002728.
3
Successful treatment of acquired perforating dermatosis with rifampicin in an Asian patient with sclerosing cholangitis.
Liver. 1999 Apr;19(2):160-3. doi: 10.1111/j.1478-3231.1999.tb00026.x.
4
Rifampicin-induced lichenoid eruptions.
BMJ Case Rep. 2014 Oct 16;2014:bcr2013202346. doi: 10.1136/bcr-2013-202346.
5
[Regarding a case of rifampicin-induced pruritus and thrombocytopenia].
Rev Mal Respir. 2014 Jan;31(1):84. doi: 10.1016/j.rmr.2013.08.005. Epub 2013 Oct 30.
6
Rifampicin as treatment for pruritus in malignant cholestasis: an example of an improper indication for anti-infective drugs.
Support Care Cancer. 1999 May;7(3):160.
7
Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile.
Int J Artif Organs. 2004 Apr;27(4):342-4. doi: 10.1177/039139880402700411.
8
[Thrombocytopenia associated with rifampicin].
An Med Interna. 1999 May;16(5):269.
9
[Use of rifabutin in cases of toxicity to rifampicin].
Rev Clin Esp. 2005 Sep;205(9):430-2. doi: 10.1157/13079071.
10
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
Aliment Pharmacol Ther. 2018 Apr;47(8):1213-1219. doi: 10.1111/apt.14579. Epub 2018 Feb 22.
引用本文的文献
1
Unusual Cause of Coagulopathy in a Child.
Oman Med J. 2024 Sep 30;39(5):e684. doi: 10.5001/omj.2024.84. eCollection 2024 Sep.
2
Severe fat-soluble vitamin deficiency suspected secondary to intrahepatic cholestasis of pregnancy: A case report.
Case Rep Womens Health. 2022 Jul 9;35:e00430. doi: 10.1016/j.crwh.2022.e00430. eCollection 2022 Jul.
3
Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous.
J Bone Jt Infect. 2021 Apr 1;6(5):131-134. doi: 10.5194/jbji-6-131-2021. eCollection 2021.
4
Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
PLoS One. 2019 Jul 10;14(7):e0219324. doi: 10.1371/journal.pone.0219324. eCollection 2019.
5
A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.
Gastroenterol Hepatol (N Y). 2019 Mar;15(3):145-154.
6
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.
7
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
Aliment Pharmacol Ther. 2018 Apr;47(8):1213-1219. doi: 10.1111/apt.14579. Epub 2018 Feb 22.
8
Novel strategies and therapeutic options for the management of primary biliary cholangitis.
Therap Adv Gastroenterol. 2017 Oct;10(10):791-803. doi: 10.1177/1756283X17728669. Epub 2017 Sep 7.
本文引用的文献
1
Pathophysiology and current management of pruritus in liver disease.
Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):89-97. doi: 10.1016/j.clinre.2010.10.007.
2
Diagnosis and management of primary sclerosing cholangitis.
Hepatology. 2010 Feb;51(2):660-78. doi: 10.1002/hep.23294.
3
Primary biliary cirrhosis.
Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906.
4
Candidate selection and organ allocation in liver transplantation.
Semin Liver Dis. 2009 Feb;29(1):40-52. doi: 10.1055/s-0029-1192054. Epub 2009 Feb 23.
5
Pathogenesis and treatment of pruritus in cholestasis.
Drugs. 2008;68(15):2163-82. doi: 10.2165/00003495-200868150-00006.
6
The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Am J Gastroenterol. 2007 Jul;102(7):1528-36. doi: 10.1111/j.1572-0241.2007.01200.x. Epub 2007 Mar 31.
7
Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials.
Liver Int. 2006 Oct;26(8):943-8. doi: 10.1111/j.1478-3231.2006.01326.x.
8
Cerebral hemorrhage associated with vitamin K deficiency in congenital tuberculosis treated with isoniazid and rifampin.
Pediatr Infect Dis J. 2002 Nov;21(11):1088-90. doi: 10.1097/00006454-200211000-00029.
9
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
Gut. 2002 Mar;50(3):436-9. doi: 10.1136/gut.50.3.436.
10
[Vitamin K deficiency syndrome caused by antituberculous agents].
Nihon Shokakibyo Gakkai Zasshi. 1997 Jun;94(6):389-97.
Zotero 插件